(Español) La FDA aprueba un nuevo tratamiento para la neumonía causada por ciertas bacterias difíciles de combatir News provided by: U.S. Food and Drug Administration May 24, 2023 SHARE THIS ARTICLE Tell a friendClose Your NameFriend Email Enter Message To Friend Sorry, this entry is only available in European Spanish.
